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Abstract
Background: The epidemiology of meningococcal meningitis in the African meningitis belt is characterised by
seasonality, localised epidemics and epidemic waves. To facilitate research and surveillance, we aimed to develop a
definition for localised epidemics to be used in real-time surveillance based on weekly case reports at the health
centre level.
Methods: We used national routine surveillance data on suspected meningitis from January 2004 to December
2008 in six health districts in western and central Burkina Faso. We evaluated eight thresholds composed of weekly
incidence rates at health centre level for their performance in predicting annual incidences of 0.4%and 0.8% in
health centre areas. The eventually chosen definition was used to describe the spatiotemporal epidemiology and
size of localised meningitis epidemics during the included district years.
Results: Among eight weekly thresholds evaluated, a weekly incidence rate of 75 cases per 100,000 inhabitants
during at least two consecutive weeks with at least 5 cases per week had 100% sensitivity and 98% specificity for
predicting an annual incidence of at least 0.8% in health centres. Using this definition, localised epidemics were
identified in all but one years during 2004-2008, concerned less than 10% of the districts’ population and often
were geographically dispersed. Where sufficient laboratory data were available, localised epidemics were exclusively
due to meningococci.
Conclusions: This definition of localised epidemics a the health centre level will be useful for risk factor and
modelling studies to understand the meningitis belt phenomenon and help documenting vaccine impact against
epidemic meningitis where no widespread laboratory surveillance exists for quantifying disease reduction after
vaccination.
Background
Most episodes of epidemic meningitis occur in the Afri-
can Meningitis Belt and have been caused by serogroup
Ao fNeisseria meningitidis (Nm) [1], although ser-
o g r o u p sW 1 3 5a n dXh a v eb e e nf o u n dt oc a u s ee p i -
demics during the last decade [2-5]. Apart from the
current introduction of serogroup A meningococcal
conjugate vaccine in Mali, Burkina Faso and Niger,
three core countries of the meningitis belt, emergency
mass vaccination campaigns with polysaccharide
serogroup A/C or A/C/W135 vaccines are organized for
epidemic response. This response is launched as soon as
weekly incidence rates, usually at the district level, meet
the currently recommended threshold for epidemic
response [6,7] of 10 or 15 cases/100,000 per week for
populations ≥ 30,000 inhabitants (threshold depending
on vaccination status and the epidemiology of previous
years) and 5 cases per week or doubling of cases over
three weeks for populations < 30,000 inhabitants. These
thresholds have been developed to predict the occur-
rence of an epidemic, previously defined at the district
level as an annual incidence of 0.1% [7], and are used to
launch reactive vaccination campaigns.
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above report on a weekly basis suspected cases of bac-
terial meningitis to the sanitary districts, where data are
aggregated, analysed and sent to the national level [8].
Furthermore, district level data aggregates are also used
for studies of disease trends, risk factor and modelling
studies which aim to understand and predict the occur-
rence of meningitis epidemics [9]. The exclusive use of
district level aggregates may be problematic as meningi-
tis epidemics often occur in a highly localised manner
and may concern only a few villages, as reported by
some studies [10-12]. For instance, when a district
declares an epidemic, high incidence rates in a few
health centres often are responsible for the increased
average incidence, while epidemics in small commu-
nities may not be recognized on the basis of district-
level data. We recently proposed a model [13] according
to which localised epidemics are the basic unit of epi-
demic meningococcal disease and occasionally form epi-
demic waves that span larger regions if additional
factors lead to a simultaneous widespread occurrence.
However, little is known about the sub-district epide-
miology of epidemic meningitis, for which evidence has
anecdotic rather than quantitative character. One major
reason for this is the absence of a definition for localised
epidemics on the health centre level. In the present
study, we aimed to establish a definition of localised
meningitis epidemics in the meningitis belt based on
health centre data and to use this definition to describe
the spatiotemporal epidemiology of localised epidemics
in Burkina Faso over half a decade.
Methods
We used routine meningitis surveillance data from six
sanitary districts in Burkina Faso, selected by conveni-
ence of existing public health collaboration. The Hauts-
Bassins sanitary region (1,608,900 inhabitants in 2007)
consisted of five districts (Secteur 15, Secteur 22,
Dandé, Houndé and Orodara sanitary districts) with 173
health centres. Boulsa sanitary district (302,600 inhabi-
tants in 2007) is located in the Centre Nord sanitary
region and comprised 28 local health centres. Where
the sanitary map changed during the observed period,
we assigned health centres to districts according to the
older map. Both regions experienced epidemic waves of
meningitis predominantly due to NmA during 1996-
1998 and 2006-2008, and predominantly due to
NmW135 during 2002-2003 [14]. Reactive mass cam-
paigns of meningococcal serogroup A/C polysaccharide
vaccine were conducted in all districts during 2008, with
the exception of Dandé and Houndé and some health
centres in eastern and southern Secteur 15, which were
vaccinated already during 2006 (information: Ministry of
Health, Burkina Faso).
On a weekly basis, the statistical units of sanitary dis-
tricts in Burkina Faso collect case reports of suspected
meningitis from health centres and aggregate them at
the district level. The case definition is based on clinical
criteria such as fever and meningeal signs without con-
sideration of laboratory confirmation [15]. Although
data are usually presented for the whole district, the
weekly health centre data are stored in specific electro-
nic files, which we collected to create a database includ-
ing reports for weeks 1/2004 to 52/2008 in Secteur 15,
Dandé and Houndé, weeks 1/2005 to 52/2008 in Secteur
22 and Orodara (all Hauts-Bassins region) and weeks 1/
2006 to 15/2008 in Boulsa (Centre Nord region). Data
before 2004 usually were missing or on paper files and
therefore not included. Weekly reports from the Bobo-
Dioulasso university hospital and district hospitals were
excluded from analyses, as it was not possible to affiliate
residency of patients (N = 813) to specific health
centres.
Population data for the calculation of incidence esti-
mates were drawn from the 1996 national census and
updated by applying an estimated annual growth rate of
3% for rural areas and 6% for urban areas [16]. Sixty-
two percent of included health centre areas had <
10,000 and 3% > 30,000 inhabitants. In Burkina Faso,
87% of the population live within 10 km of a health cen-
tre [17].
For descriptive analyses, we calculated weekly inci-
dence rates (WIR) as weekly number of cases per
100,000 inhabitants and annual incidences (%) as annual
number of cases per 100 inhabitants. We used Poisson
models to test the variability of annual incidences within
district years (Wald test) and to test the difference of
annual incidences between health centres with and with-
out localised epidemics. We chose as the primary refer-
ence an annual incidence above the 95th percentile of
annual incidences in all health centre years in our data
base, which was 0.4%. The secondary reference corre-
sponded to the incidence reported during a focal epi-
demic in Burkina Faso during 2006, which reached 0.8%
in one health centre [11]. We then formulated and
tested eight thresholds of WIR at the health centre level
to predict the occurrence of a localised epidemic: The
first threshold was the recommended threshold for epi-
demic response in populations with < 30,000 inhabi-
tants, applied to health centre level data (RT@HC) [6].
The other seven thresholds were WIRs of ≥ 25, 50, 75,
100, 150, 200 or 250 cases per 100,000 during at least
two consecutive weeks and ≥ 5 cases reported during at
least one of the two weeks. We added the requirement
of two consecutive weeks and the minimum number of
cases to limit bias due to operational issues such as
non-continuous reporting or incidence estimates with
wide confidence intervals in small populations. These
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identified health centres with WIR of ≥ 25 during at
least two consecutive weeks and at least five cases
reported during at least one. The eight thresholds were
evaluated for their sensitivity and specificity in predict-
ing health centres with eventual annual incidence of ≥
0.4% and ≥ 0.8%. The threshold with the optimised diag-
nostic performance was chosen as the definition of loca-
lised epidemics and was used to describe the
spatiotemporal epidemiology of localised epidemics in
the six districts during 2004-2008. The duration of loca-
lised epidemics included the two weeks required by the
definition. Using Spearman’s correlation, we evaluated
the hypotheses of correlations between district level
annual incidence and characteristics of the localised epi-
demics in the district, such as number of localised epi-
demics, size of the health centre area population,
median peak WIR and median annual incidence in loca-
lised epidemics.
All analyses were performed on Stata/IC10 software
(StataCorp Texas USA). We did not use any information
that could allow an individual patient identification,
therefore no ethics committee approval was sought for
this research, for which we obtained authorization by
the Ministry of Health of Burkina Faso.
Results
A total of 35,078 weekly reports were included. Among
the 7,000 reported suspected cases, 93.7% occurred dur-
ing calendar weeks 1-20, corresponding to the meningi-
tis season with the typical bell shaped incidence curve
peaking by end of March and seen every year at district
level (Figure 1). During the observed 26 district years,
the median annual incidence (5
th and 95
th percentile)
was 0.05% (0.02% and 0.25%) and epidemics at the dis-
trict level were declared twelve times. Peak WIR (per
100,000) in the six districts were < 10 during 2004 and
2005, 10-60 during 2006, 10-40 during 2007 and 10-30
during 2008. At the health centre level, the highest
annual incidence observed was 6.1% and 7.4%, observed
in two health centres of the sanitary district Secteur 15
during 2006 (Figure 2).
Annual incidences differed significantly between
health centres within the same district year (P <0 . 0 0 1 )
(Figure 2) and this heterogeneity was greater in district
years with official epidemic declaration at the district
level: the interquartile range of annual incidences
among health centres of the same district year was on
median 1.41% (range 0.72-2.29%) in district years with
epidemic declaration and 0.03% (0.01-0.09%) in district
years without epidemic declaration (Table 1).
When the threshold for localised epidemics was varied
from LE25 to LE250, sensitivity to identify health cen-
tres with annual incidence ≥ 0.4% (≥ 0 . 8 % )v a r i e df r o m
94% to 27% (100% to 56%) and specificity from 95% to
100% (93% to 100%) (Figure 3). RT@HC had a sensitiv-
ity of 94% (100%) and a specificity of 91% (89%) in pre-
dicting an annual incidence of ≥ 0.4% (≥ 0.8%) with a
positive predictive value of 33% (17%) and a negative
predictive value of 100% (100%). LE75 had a sensitivity
of 85% (100%) and a specificity of 99% (98%) in predict-
ing an annual incidence of ≥ 0.4% (≥ 0.8%) with a posi-
tive predictive value of 87% (50%) and a negative
predictive value of 99% (100%). We chose this threshold
as the definition of localised epidemics based on its
robust performance to predict both annual incidence ≥
0.4% and ≥ 0.8%.
Applying the definition LE75 to the health centre sur-
veillance data, we identified 0, 2, 20, 7 and 3 localised
epidemics per year during 2004-2008 (Table 1 and 2).
Within district years, annual incidence in health centres
with localised epidemics (LE75) were significantly higher
than in those without (P < 0.001).
In 9 out of 12 district years with declaration of an epi-
demic at the district level a localised epidemic was iden-
tified in at least one health centre. By contrast, two
localised epidemics were identified in one district year
without epidemic declaration (Table 1).
During 2005, two localised epidemics occurred in the
western part of the Hauts-Bassins region near the Mal-
ian border, with a distance of 100 km to each other.
During 2006 in the same region, 17 of the 20 localised
epidemics occurred in a geographically contingent zone
of about 90 km length and 50 km width which belonged
to five different sanitary districts on the current sanitary
map, however leaving several health centres within this
zone without localised epidemic (Figure 4). In addition,
localised epidemics occurred in two neighbouring health
Figure 1 Weekly incidence rates of suspected meningitis in six
sanitary districts of Burkina Faso, 2004-2008. The districts are
situated in the sanitary regions Hauts-Bassins (Dandé, Houndé,
Orodara, Secteur 15 and Secteur 22) and Centre Nord (Boulsa). The
weekly incidence rates (per 100,000 inhabitants) are based on the
national routine case reporting system and population estimates as
provided by sanitary authorities.
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Page 3 of 10centres 70 km to the Nord-West from this cluster and
another 60 km to the East. During 2007, five localized
epidemics occurred at the borders of the Hauts-Bassins
region, one each in the East (the same health centre as
in 2006), the North and the West, and two neighbouring
health centres in the North-West. During 2008, one sin-
gle localised epidemic occurred in the South-Western
part of the region. In the sanitary district of Boulsa, two
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Figure 2 Annual incidences at health centre and district level in six sanitary districts of Burkina Faso, 2004-2008. Boxplots show median,
25th and 75th percentile and range of annual incidences at health centre level and red marks show district level annual incidences. Dotted lines
indicate annual incidence of 0.1 per 100, previously used as a retrospective definition of epidemics at the district level [7].
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Page 4 of 10Table 1 Surveillance of suspected meningitis in six sanitary districts in Burkina Faso, 2004-2008.
District level Health center level
Year District Population
size in 1000
(number of
HC)
Official
epidemic
declaration
Annual
incidence
per 100
(case count)
Peak
WIR
HC
population
size in
1000
Number of
HC with
localised
epidemics*
Annual incidence
per 100 in HC with
localised epidemics
†
Annual incidence per
100 in HC without
localised epidemics †
2004
Dandé 213.3 (21) No 0.04 (83) 4 9.4 (1.8-22.3) 0 na na
Houndé 205.3 (25) No 0.03 (64) 5 8.4 (3.0-26.3) 0 na na
Secteur
15
351.5 (31) No 0.04 (153) 4 6.7 (1.5-50.3) 0 na na
2005 na na
Dandé 219.7 (21) No 0.03 (72) 5 9.7 (1.8-23.0) 0 na na
Houndé 212.8 (25) No 0.02 (35) 2 8.7 (3.1-27.2) 0 na na
Orodara 244.5 (35) No 0.04 (106) 4 6.3 (1.1-19.3) 2 0.94 (0.84-1.04) 0.01 (0-0.18)
Secteur
15
367.7 (32) No 0.02 (89) 3 6.9 (1.5-53.4) 0 na na
Secteur
22
405.9 (21) No 0.004 (17) 1 12.8 (2.2-
76.0)
0n a n a
2006 na na
Boulsa 269.1 (30) Yes 0.10 (255) 12 9.9 (3.5-18.3) 0 na na
Dandé 225.6 (22) Yes 0.12 (275) 23 9.5 (1.9-21.5) 2 0.68 (0.49-0.87) 0.08 (0-0.33)
Houndé 220.2 (25) Yes 0.25 (555) 53 9.0 (3.2-28.2) 8 0.60 (0.31-1.11) 0.14 (0.01-0.38)
Orodara 269.9 (40) No 0.05 (132) 9 5.9 (1.1-19.9) 0 na na
Secteur
15
384.8 (34) Yes 0.57 (2182) 83 6.1 (1.57-6.6) 10 1.44 (0.32-7.42) 0.13 (0.02-0.49)
Secteur
22
431.2 (23) No 0.04 (163) 8 12.7 (2.3-
80.5)
0n a n a
2007
Boulsa 272.9 (30) Yes 0.14 (387) 20 10.0 (3.6-
18.6)
2 0.91 (0.53-1.30) 0.08 (0.0-1.30)
Dandé 232.2 (24) Yes 0.08 (196) 16 9.2 (2.0-22.1) 1 0.33 0.03 (0-0.29)
Houndé 227.8 (28) Yes 0.09 (196) 9 7.9 (3.3-18.0) 1 0.59 0.03 (0-0.49)
Orodara 278.2 (40) Yes 0.17 (467) 37 6.1 (1.1-20.5) 3 0.45 (0.32-2.05) 0.02 (0-0.45)
Secteur
15
388.5 (34) No 0.05 (181) 6 6.3 (1.6-60.0) 0 na na
Secteur
22
454.2 (25) No 0.03 (140) 4 12.9 (2.0-
72.7)
0n a n a
2008
Boulsa 272.7 (30) Yes 0.14 (372) 29 10.1 (3.6-
18.9)
2 1.12 (0.82-1.41) 0.07 (0.0-1.41)
Dandé 239.1 (24) No 0.04 (97) 5 9.5 (2.1-22.8) 0 na na
Houndé 235.6 (28) Yes 0.11 (267) 22 8.2 (3.5-18.7) 0 na na
Orodara 286.9 (43) Yes 0.08 (241) 12 5.64 (1.2-
18.7)
1 2.93 0.02 (0-0.32)
Secteur
15
412.3 (35) Yes 0.04 (154) 21 6.60 (1.7-
63.6)
0n a n a
Secteur
22
478.6 (25) No 0.03 (121) 6 13.5 (2.0-
77.1)
0n a n a
Population and incidence in 26 surveyed districts years at the district level and at the health centre level. If not indicated otherwise, the health centre level
columns show median (range).
Peak WIR, highest weekly incidence rate (per 100,000) observed during a given year
HC, health centers
na, not applicable
* A localised epidemic (LE) was defined at the health centre level as 75 suspected meningitis cases reported per 100,000 inhabitants during at least two
consecutive weeks, with a minimum of five cases within at least one week.
† In all district years, the annual incidences between health centres with and without localised epidemic differed significantly (P < 0.001, Poisson model).
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Page 5 of 10localised epidemics occurred during 2007 in the North
and South and two in 2008 in the central area.
Localised epidemics occurred in small populations: the
median size of concerned health centre populations was
6,702 (range 1,068-22,472) corresponding in median to
6% (range 1%-25%) of the district population (Table 2).
The criteria for localised epidemics were fulfilled in
median during calendar week 10 (range 3-13) and epi-
demics lasted for 3 weeks (2-12). Where sufficient
laboratory data were available, localised epidemics were
exclusively due to meningococci (Table 2). Within dis-
trict years, the district annual incidence correlated posi-
tively with the number of localised epidemics identified
in the district (rho = 0.829, P = 0.003), the total popula-
tion referring to health centres concerned by localised
epidemics (rho = 0.878, P < 0.001) and the percentage
of district population concerned (rho = 0.859, P =
0.002), but not with the median annual incidence
observed in health centre years with localised epidemics
(rho = 0.024, P = 0.947), median peak WIR (rho =
-0.031 P = 0.931) or median duration of localised epi-
demics (rho = 0.290, P = 0.417).
Districts tended to declare epidemics earlier than loca-
lised epidemics could have been identified by LE75
(Table 2). Using RT@HC, 95 localised epidemics were
detected, 40 after epidemic declaration in the district, 20
without occurrence of an epidemic declaration in the
district and 35 with consecutive epidemic declaration in
the district (yielding a PPV of 63% for epidemic detec-
tion by RT@HC compared to district declaration). In 20
of the 75 health centres (27%) situated in districts that
declared an epidemic during a given year, a localised
epidemic was identified by RT@HC at least one week
earlier than the district declared the epidemic.
Discussion
This evaluation is the first attempt to quantify and char-
acterize localised meningitis epidemics in the meningitis
belt at the health centre level. The advantage of our
definition in comparison to existing district level
approaches [18,19] is that it allows attributing an epi-
demic event precisely to specific communities and the
exact calendar weeks, while the analysis is based on
national case reporting systems which collect data routi-
nely in virtually all sanitary districts of the meningitis
belt and are available for several past years.
By applying a definition of ≥ 75 cases per 100,000
inhabitants during at least two weeks and ≥ 5 cases dur-
ing at least one of these weeks to these health centre
level data, we could describe several characteristics of
meningitis epidemiology in general, and localised epi-
demics in particular. First, we observed great heteroge-
neity in weekly and annual incidence among health
centres of the same district, especially during epidemic
years. This confirms that, to fully understand the
dynamic of meningitis epidemics, health centre level
data should be analysed.
Secondly, in most years, localised epidemics concerned
small communities (< 5,000 inhabitants in several
instances), small portions of the district population (as
low as 1%), restricted geographic areas (individual health
centre zones) and short periods (as short as two weeks).
These elements together point to the fact that epidemics
at the community level are events that are distinct from
ubiquitous hyper-endemic meningitis incidence during
the dry season, which is most likely driven by climatic
factors [19,20], and distinct also from epidemic waves
across larger regions, which occur every 10 years or so
[21]. While no strong evidence exists on what makes
these localised epidemics occur, specific spatially
restricted factors other than climate or meningococcal
strains are likely responsible, possibly including micro-
epidemics of viral infections [13].
Third, the importance of the epidemic at the district
level correlated with the number of localised epidemics
in the district, but not with the duration or the level of
incidence rates during the localised epidemics. If epi-
demics at the district level are considered the smallest
form of epidemic waves, our results lend support to the
concept that epidemic waves are the sum of individual
Figure 3 Performance of localised epidemic definitions in
predicting annual meningitis incidences at health centre level.
The different marks represent sensibility and 1-specificity of eight
localised epidemic definitions in predicting annual incidences of
suspected meningitis at the health centre level in Hauts-Bassins and
Centre Nord sanitary region, Burkina Faso, 2004-2008. Full and bold
marks represent the performance in predicting annual incidences ≥
0.4%. Empty or faint marks represent the performance in predicting
annual incidences ≥ 0.8%. Definitions for localised epidemics are:-
the recommended threshold for epidemic response applied to
health centre level data (oblique cross, RT@HC); or - based on
different thresholds of weekly incidence rates per 100,000
inhabitants [≥ 25 (bar), ≥ 50 (big circle), ≥ 75 (straight cross, FE75),
≥ 100 (triangle), ≥ 150 (diamond), ≥ 200, (small circles), ≥ 250
(squares)] with incidences maintained during ≥ 2 weeks and with ≥
5 cases per week.
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number of localised epidemics that occur simulta-
neously. In consequence, the occurrence of epidemic
waves would be triggered by a greater than usual geo-
graphic expansion of local factors that drive the epi-
demic, rather than the quality or intensity of a distinct
cause of epidemic waves.
Fourth, localised epidemics with appropriate labora-
tory evaluation appeared to be caused by meningococ-
cus and not by pneumococcus, although the latter was
occasionally identified. Despite the fact that pneumo-
cocci are responsible for almost half of bacterial menin-
gitis cases in the meningitis belt [22,23] and cause
meningitis with pronounced seasonality, no localised
epidemic so far has been reported due to pneumococci,
which suggests that the focal epidemic pattern is limited
to meningococci. Serogroups W135 or X were found
only sporadically in Burkina Faso during the observed
years, such that we cannot evaluate whether these ser-
ogroups cause localised epidemics, as well. An analysis
of the recent years with high pneumococcal contribution
to seasonal meningitis and the NmX epidemic in Bur-
kina Faso during 2010 [5] should evaluate these hypoth-
eses. Because only a relatively small proportion of
suspected cases actually are meningococcal meningitis
cases, as some studies have shown [4,22,24], epidemiolo-
gical analyses of these surveillance data can yield evi-
dence with only limited precision. If the explosive
character of localised epidemics was typical for menin-
gococci, the proposed definition could help overcome
this limitation of routine surveillance data and allow
analyses that are specific for meningococcus.
Lastly, localised epidemics occurred in 38% of the 26
evaluated district years, while in the total evaluated
population (1.9 million), at least two epidemics were
identified during each year, except 2004. That year
showed moderate meningitis incidence in Burkina Faso
and it is likely that localised epidemics occurred else-
where in the country. We hypothesize that in a some-
what larger population than that evaluated here (e. g.,
three sanitary regions), several localised epidemics occur
every year, even outside epidemic waves. The
Table 2 Characteristics of localised epidemics in six sanitary districts, Burkina Faso, 2004-2008.
Year District Number
of HC
with LEs
Calendar week of
epidemic
declaration at the
district level
Calendar week when
LE definition was
met in the HC
(median, range)
Duration of
individual
LE, median
(range) *
Total population
in HC with LE,
(% of district
population)
Predominant agent if
laboratory-
confirmation during
localised epidemic †
Peak WIR in
HC with LE,
median
(range)
2005
Orodara 2 no declaration 8 (7-9) 2.5 (2-3) 4,050 (2) - 318 (169-
468)
2006
Dandé 2 11 13 (12-14) 2.5 (2-3) 6,850 (3) 28 NmA/31 (2) 261 (202-
320)
Houndé 8 9 11.5 (10-14) 3 (2-5) 55,180 (25) 30 NmA/30 (2) 191 (115-
278)
Secteur
15
10 5 10 (4-14) 5 (2-12) 97,770 (25) 30 NmA/31 (1) 343 (100-
1860)
2007
Boulsa 2 8 10 (7-13) 6 (2-10) 25,390 (9) 8 NmA/3 Sp/15 (3) 190 (93-286)
Dandé 1 12 14 3 (2-5) 14,290 (6) - 91
Houndé 1 12 13 2 5,640 (2) 2 NmA/1 Sp/3 (1) 124
Orodara 3 11 13 (12-14) 3 (2-6) 28,570 (10) 10 NmA/2 Sp/12 (1) 104 (94-582)
2008
Boulsa 2 10 10.5 (10-11) 5 (4-6) 13,830 (5) 11 NmA/5 Sp/16 (3) 276 (185-
366)
Orodara 1 8 8 6 2,490 (1) 4 NmA/4 (1) 561
A localised epidemic (LE) was defined at the health centre level as 75 suspected meningitis cases reported per 100,000 inhabitants during at least two
consecutive weeks, with a minimum of five cases within at least one week.
WIR, weekly incidence rate
HC, health centres
LE, localised epidemic
NmA, meningococcal serogroup A
* In weeks, includes the week before definition was met
† Number of epidemic agent over number of laboratory-confirmed bacterial meningitis cases
(1) AMP Mobile laboratory [25]
(2) Laboratory surveillance by PCR at Centre Muraz, Bobo-Dioulasso [23]
(3) District level data as reported by Ministry of Health, Epidemiological surveillance department. Burkina Faso
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Page 7 of 10disappearance of these localised epidemics could be
used for quantifying the impact that meningococcal ser-
ogroup A conjugate vaccine (MenAfriVac
®) will have on
epidemic meningitis. The introduction of MenAfriVac
®
in the meningitis belt is expected to substantially change
the meningitis epidemiology and a key issue will be to
evaluate the impact of the vaccine on the frequency and
extend of epidemics. It is possible that the presented
definition of epidemics at the health centre level will
allow quantifying the long-term impact in a sensitive
and economic way, especially in areas where no wide-
spread laboratory surveillance is conducted.
In three instances, an epidemic was declared at district
level although the proposed definition LE75 did not iden-
tify any localised epidemic. Detailed analyses showed that
typically a few health centres had WIR above 75 per
100,000 but only during one week or with < 5 cases per
week. The proposed definition appears to have a reduced
sensitivity in these instances, but for the sake of robust-
ness and specificity of the definition, as needed for risk
factor research, we preferred to maintain the requirement
of two consecutive weeks with high WIR.
While the proposed definition of localised epidemics
at the health centre level (LE75) did not improve timeli-
ness of epidemic declaration at the health centre level
compared to the current practice of district level analy-
sis, our study showed that if RT@HC was used, epi-
demics could be identified geographically precisely and
in one quarter of instances at least one week earlier
than by district level analysis. This may be important for
reactive mass vaccine campaigns, which will remain
necessary after MenAfriVac
® i n t r o d u c t i o n ,a tl e a s tf o r
occasional serogroup W135 epidemics [2,3]. Some coun-
tries, such as Mali and Togo, do organize reactive vac-
cine campaigns based on health centre level incidence
data and therefore hold vaccine stocks at district level.
Many factors influence the effectiveness and costs of a
reactive vaccination campaign (speed of data transmis-
sion, campaign logistics, and target population) and the
usefulness of health centre level analysis of surveillance
data for informing vaccination strategies need to be
evaluated in more detail on larger data sets.
Our study has several limitations. We used data from
a surveillance system without routine quality control
®
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Page 8 of 10and some biases may arise. For example, heterogeneity
between health centre level incidences may result from
differences in reporting practices. Incidences during the
rainy season were comparable in health centres across
all districts, but differences in practices may arise speci-
fically during the meningitis season. We included only a
small sample of districts spanning five years and there
may be geographic variations in the nature of localised
epidemics. However, our study included two years out-
side epidemic waves (2004-5) and three years of an epi-
demic wave (2006-8), and therefore could be
representative of the longer-term variations in epide-
miology in Burkina Faso. Data on past vaccination cam-
paigns and coverage at the health centre level were not
available. Population immunity likely is an important
factor of epidemic occurrence and heterogeneous vacci-
nation coverage across the district may explain why
some outbreaks remain localised and why outbreaks
may occur several years in a row despite vaccination
campaigns.
We excluded cases reported from reference medical
centres as they could not be assigned to a specific health
care centre population. This certainly led to an underes-
timation of incidence rates, especially in health centres
close to reference centres. Similarly, patients infected in
other health centres, districts or regions may have been
included in a health centre case report due to consulta-
tion preference or travel. However, we believe that our
definition of localised epidemics is sufficiently robust
n o tt ob eb i a s e db yt h i s ,e x c e p ti nt h ec a s eo fm a j o r
population movements.
To validate the approach, similar analyses should be
conducted on a wider geographical area and include
more recent years that were characterized by low ser-
ogroup A incidence and high serogroup X or pneumo-
coccal incidence, use spatial epidemiological methods
and include more systematic laboratory information on
the aetiology of meningitis epidemics and vaccination.
Also, it will be interesting to evaluate at which interval
localised epidemics occur in individual communities.
Conclusion
In summary, this evaluation of health centre level data
confirmed that localised epidemics are events that are
distinct from hyperendemicity or regional epidemic
waves. Further research should identify the factors that
lead to transition from hyperendemic meningitis inci-
dence during the dry season to localised epidemics, and
from individual localised epidemics to larger epidemic
waves. The definition we proposed and used to describe
characteristics of localised epidemics should be validated
on larger data sets and may be useful for future risk fac-
tor and modelling studies and for assessment of vaccine
impact on epidemic meningitis in the African meningitis
belt.
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